Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 3-(4-fluorophenyl)ala-3-(3-bis(2-chloroethyl)aminophenyl)ala-met Ethyl Ester
2. 3-(4-fluorophenyl)alanyl-3-(3-bis(2-chloroethyl)aminophenyl)alanyl-methionine Ethyl Ester
3. Ambamustine
4. Ptt 119
5. Ptt-119
6. Ptt.119
1. Ptt-119
2. 83996-50-3
3. Ptt 119
4. Ethyl (2s)-2-[[(2s)-2-[[(2s)-2-amino-3-(4-fluorophenyl)propanoyl]amino]-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoyl]amino]-4-methylsulfanylbutanoate;hydrochloride
5. Ethyl (2s,5s)-5-[[(2s)-2-amino-3-(4-fluorophenyl)propanoyl]amino]-6-[3-[bis(2-chloroethyl)amino]phenyl]-2-(2-methylsulfanylethyl)-4-oxohexanoate;hydrochloride
6. Ambamustine Hcl
7. Ccris 1548
8. Pt 119
9. Dtxsid201004255
10. 2-amino-n-[1-{3-[bis(2-chloroethyl)amino]phenyl}-5-(ethoxycarbonyl)-7-(methylsulfanyl)-3-oxoheptan-2-yl]-3-(4-fluorophenyl)propanimidic Acid--hydrogen Chloride (1/1)
| Molecular Weight | 665.1 g/mol |
|---|---|
| Molecular Formula | C30H41Cl3FN3O4S |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 20 |
| Exact Mass | 663.186739 g/mol |
| Monoisotopic Mass | 663.186739 g/mol |
| Topological Polar Surface Area | 127 Ų |
| Heavy Atom Count | 42 |
| Formal Charge | 0 |
| Complexity | 785 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
ABOUT THIS PAGE
36
PharmaCompass offers a list of Ambamustine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ambamustine manufacturer or Ambamustine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ambamustine manufacturer or Ambamustine supplier.
PharmaCompass also assists you with knowing the Ambamustine API Price utilized in the formulation of products. Ambamustine API Price is not always fixed or binding as the Ambamustine Price is obtained through a variety of data sources. The Ambamustine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ambamustine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ambamustine, including repackagers and relabelers. The FDA regulates Ambamustine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ambamustine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ambamustine supplier is an individual or a company that provides Ambamustine active pharmaceutical ingredient (API) or Ambamustine finished formulations upon request. The Ambamustine suppliers may include Ambamustine API manufacturers, exporters, distributors and traders.
Ambamustine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ambamustine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ambamustine GMP manufacturer or Ambamustine GMP API supplier for your needs.
A Ambamustine CoA (Certificate of Analysis) is a formal document that attests to Ambamustine's compliance with Ambamustine specifications and serves as a tool for batch-level quality control.
Ambamustine CoA mostly includes findings from lab analyses of a specific batch. For each Ambamustine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ambamustine may be tested according to a variety of international standards, such as European Pharmacopoeia (Ambamustine EP), Ambamustine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ambamustine USP).
